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ABSTRACT
Amultiplex PCR was developed for the detection of the following genes characteristic of diarrhoeagenic
Escherichia coli (DEC): verocytotoxins 1 (vtx1) and 2 (vtx2), characteristic of verocytotoxin-producing
E. coli (VTEC); intimin (eae), found in enteropathogenic E. coli (EPEC), attaching and effacing E. coli and
VTEC; heat-stable enterotoxin (estA) and heat-labile enterotoxin (eltA), characteristic of enterotoxigenic
E. coli (ETEC); and invasive plasmid antigen (ipaH), characteristic of enteroinvasive E. coli (EIEC) and
Shigella spp. The method allowed the simultaneous identification of all six genes in one reaction, and
included a 16S rDNA internal PCR control. When applied to pure cultures from a reference strain
collection, all virulence genes in 124 different DEC strains and 15 Shigella spp. were identified correctly,
and there were no cross-reactions with 13 non-E. coli species. The detection limit of the method was
102)103 DEC CFU ⁄PCR in the presence of 106 non-target cells. When the multiplex PCR was tested with
colonies from plate cultures of clinical stool samples, it was a faster, more sensitive, less expensive and
less laborious diagnostic procedure than DNA hybridisation. When used with DNA purified from
spiked stool samples (by two different commercial kits), the method had a detection limit of
106 CFU ⁄mL stool sample.
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INTRODUCTION
Diarrhoeagenic Escherichia coli (DEC) is a signifi-
cant contributor to diarrhoeal disease throughout
the world [1–3]. The symptoms of DEC illness
range from self-limiting watery diarrhoea to life-
threatening illness, with children, the elderly,
those suffering from malnutrition, and immuno-
compromised individuals being at higher risk of
developing serious complications. Based on the
pathogenesis, clinical manifestations and pres-
ence of specific virulence factors, the major DEC
groups include [4]: (i) verocytotoxin-producing
E. coli (VTEC); (ii) enteropathogenic E. coli
(EPEC); (iii) enterotoxigenic E. coli (ETEC); (iv)
enteroinvasive E. coli (EIEC); and (v) enteroag-
gregative E. coli (EAggEC).
VTEC strains produce verocytotoxins VT1
and ⁄ or VT2, encoded by the vtx1 and vtx2 genes,
respectively. VTEC strains account for the most
severe clinical manifestations among the DEC
strains, including gastroenteritis and bloody diar-
rhoea, sometimes leading to haemolytic uraemic
syndrome. EPEC strains cause characteristic
attaching andeffacing lesions in the small intestine,
which are associated with the virulence factor
intimin, encoded by the eae gene. The eae gene may
also be present in VTEC strains, and is always
present in attaching and effacing E. coli strains,
which are less virulent or non-virulent. ETEC
strains cause diarrhoea because they produce one
or both of two enterotoxins, heat-stable enterotoxin
and heat-labile enterotoxin, encoded by the est and
elt genes, respectively. EIEC strains are related
closely to Shigella spp. with respect to both
phylogeny and pathogenesis. Characteristic of the
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invasive phenotype of both EIEC strains and
Shigella spp. is the ipaH gene, which is present in
several copies on both the chromosome and the
invasive plasmid (pInv). EAggEC strains are prob-
ably a frequent cause of diarrhoea in both the
industrialised and the developing world, and
several putative virulence factors have been found
in EAggEC strains. However, all these virulence
factors are also encountered in other E. coli groups,
and none occur in all EAggEC strains. Therefore,
EAggEC strains cannot be identified simply by
detection of specific virulence factors or genes. Cell
adherence assays comprise the reference standard
method, and are the only truly reliable methods
described to date for identifying these strains. A
large, diverse group of E. coli strains, characterised
by their diffuse adherence to cells, has also been
described. The pathogenic potential of this group
still needs to be confirmed.
Serotyping and biochemistry have been
widely applied in the diagnosis of gastrointes-
tinal pathogens, but cannot be used for conclu-
sively identifying DEC groups. Therefore,
identification of the characteristic virulence
genes is an obvious choice for DEC diagnostics.
Since the discovery of the virulence genes, DNA
hybridisation has been a successful method for
the detection of DEC [5–11], but PCR has
become the preferred diagnostic tool, because
of the shorter time required for analysis and the
simpler and less expensive experimental proce-
dure. PCR analyses for identification of DEC
groups have been designed that detect one or a
few genes per reaction [10,12–24]. However,
PCRs are now being designed to detect multiple
genes in the same reaction, thereby further
reducing the cost and time required for the
experimental procedure [22,25–33].
The aim of the present study was to develop
a PCR method for routine diagnostic identifica-
tion of DEC infections caused by VTEC, EPEC,
ETEC and ⁄ or EIEC by simultaneous and specific
detection of the six virulence genes (eltA, estA,
vtx1, vtx2, eae and ipaH). As new gene variants
are constantly being submitted to GenBank, the
most complete and updated sequence data were
used to design primers for the detection of
individual genes. For routine diagnostic purpo-
ses, the assay also included the UNG-dUTP
carryover prevention system, together with an
additional primer pair targeting a universal 16S
rDNA sequence as a positive internal PCR
control. This study describes the method design
and its validation using DNA obtained from
primary stool cultures in comparison with the
reference standard DNA hybridisation tech-
nique. The assay’s capabilities were also tested
with spiked stool specimens in order to further
reduce the analysis time by circumventing the
initial culture step.
MATERIALS AND METHODS
Strains and DNA preparations
All strains used in this study were obtained from the
International Escherichia and Klebsiella Centre (WHO), Statens
Serum Institut, Copenhagen, Denmark. Before analysis, select-
ed strains were grown on agar plates overnight at 37C. One
colony was transferred to 100 lL of Chelex 100 (Bio-Rad,
Hercules, CA, USA) 10% w ⁄v in 10 mM Tris-HCl, 1 mM
EDTA, pH 8, boiled for 5 min, and centrifuged briefly. The
resulting supernatant (5 lL) was used directly as a DNA
template in PCRs. Liquid cultures for the sensitivity and
spiking experiments were prepared from single colonies
inoculated and grown in Luria broth overnight at 37C. Cell
densities of the liquid cultures were determined by counting
colonies from ten-fold dilutions on three replicate plates. For
the sensitivity experiment with pure cultures, 5 lL of liquid
culture was diluted ten-fold in Chelex 100 in 10 mM Tris-HCl,
1 mM EDTA, pH 8, and treated as above. These dilution series
resulted in 107)10)1 and 0 DEC CFU ⁄PCR. Four dilution
series were constructed: (i) an ETEC strain (estA and eltA)
and an EIEC strain (ipaH); (ii) a VTEC strain (vtx1, vtx2 and
eae); (iii) an ETEC strain (estA and eltA) and an EIEC strain
(ipaH), combined with a non-pathogenic E. coli strain at
106 CFU ⁄PCR in each dilution; and (iv) a VTEC strain (vtx1,
vtx2 and eae) combined with a non-pathogenic E. coli strain at
106 CFU ⁄PCR in each dilution.
Culture and DNA preparation from stool
Stool samples (c. 0.1 g) were stirred in 2 mL of sterile buffered
saline (80 mM NaCl, 50 mM Na2HPO4, 10 mM KH2PO4,
pH 7.38). An aliquot (c. 10 lL) of this suspension was plated
on an SSI enteric medium plate (SSI Diagnostica, Hillerød,
Denmark [34]) and grown overnight at 37C. E. coli strains may
growwith different colonymorphologies on thismedium. From
these plates, two examples of each morphologically different
E. coli-like colony typewere selected and pooled, andDNAwas
extracted as described above, except that the supernatant was
diluted ten-fold in water before PCR analysis. A sweep of
culturematerial fromanarea on theplatewith semi-confluent or
confluent growth was also tested, and this material was treated
asdescribedabove.Colonies andareasof confluentgrowthwere
also transferred to individual spots on a nylon membrane for
subsequent analysis by DNA hybridisation.
Two bloody and two non-bloody stool samples (all negative
for gastrointestinal pathogens) were chosen for the spiking
experiments. Liquid cultures of either a VTEC strain (contain-
ing eae, vtx1 and vtx2), or an ETEC strain (containing eltA and
estA) combined with an EIEC strain (containing ipaH), were
added to the stools, resulting in final concentrations in stools of
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108, 107, 106, 105, 104, 103, 102 and 0 DEC CFU ⁄mL. Template
DNA for the PCR was extracted from stools using two
commercially available DNA extraction systems, the automatic
KingFisher mL system (Thermo Labsystems, Vantaa, Finland)
and the manual QIAamp DNA Stool Kit (Qiagen, Hilden,
Germany), according to the manufacturers’ instructions. Ten-
microlitre samples of the spiked stools were also grown on SSI
enteric medium plates as described above. DNA was extracted
from morphologically different colonies by the simple boiling
procedure, and was then analysed by PCR as described above.
DNA hybridisation
DNA hybridisation was performed with probes for vtx1 [35],
vtx2 [11], eae [36], elt and estA-h, and estA-p [6–8] and ipaH [37].
Cell material from the SSI enteric medium plate was allowed to
grow on the nylon membrane positioned on top of an agar
plate. The colonies were lysed, denatured and neutralised
using standard conditions and then hybridised with digoxige-
nin-labelled probes under stringent conditions according to
the manufacturer’s recommendations (Roche Diagnostics,
Mannheim, Germany).
Multiplex PCR
PCRs were performed in a total reaction volume of 25 lL
containing 1 · PCR buffer (50 mM Tris-HCl, 10 mM KCl,
5 mM (NH4)2SO4, pH 8.3), 2.6 mM MgCl2, 260 lM each of
dATP, dCTP and dGTP, 520 lM dUTP, 0.15 U of UNG
(Applied Biosystems, Foster City, CA, USA), 1.25 U of Taq
polymerase (FastStart; Roche Diagnostics), and the 16 primers
shown in Table 1 in the listed concentrations (DEC Primer
Mix; SSI Diagnostica, Hillerød, Denmark). These included a
primer pair for the 16S rDNA gene as a positive internal PCR
control. Template volumes were 5 lL when PCRs were
performed with bacterial cultures and stool samples extracted
with the QIAamp DNA Stool Kit, and 1 lL when stool samples
were extracted with the KingFisher mL system. Amplification
conditions comprised 94C for 6 min, followed by 35 cycles of
94C for 50 s, 57C for 40 s and 72C for 50 s, and finally 72C
for 3 min. Amplicons were analysed by electrophoresis on
agarose 1.5% w ⁄v gels using standard conditions, followed by
staining with ethidium bromide.
RESULTS
Assay specificity tested with reference strains
The assay specificity was tested with a strain
collection that included three non-pathogenic
E. coli strains, 15 Shigella spp. and 124 different
DEC strains, representing a variety of different
serotypes and the following genetic subtypes:
vtx1, vtx1c, vtx2, vtx2c, vtx2d, vtx2e (according to
[38]), eae-a, eae-b, eae-c, eae-d, eae-, eae-f and eae-h.
Primer sequences, gene targets and amplicon
sizes are listed in Table 1. The six virulence genes
were identified correctly in all strains (Table 2).
As expected, E. coli strains characterised by their
diffuse adherence to cells, EAggEC strains (con-
taining the EAST1 toxin) and non-pathogenic
E. coli strains did not produce any PCR products,
except the 16S rDNA band. Fig. 1 shows the
results obtained with 13 selected reference strains.
Amplicons were identified by comparison with
size markers; successful amplification of the 16S
rDNA band (1062 bp) in each PCR was required
for a valid result.
The specificity was also tested using 13 non-
E. coli intestinal colonising species grown on SSI
enteric medium, comprising Salmonella
Enteritidis, Salmonella Paratyphi A, Salmonella
Typhimurium, Vibrio cholera non-O1, Aeromonas
caviae, Proteus vulgaris, Pseudomonas aeruginosa,
Plesiomonas shigelloides, Serratia marcescens,
Klebsiella pneumoniae, Citrobacter freundii, Salmon-
ella Cholerasuis and Yersinia enterocolitica. None
of these bacteria gave rise to PCR products,
except the 16S rDNA amplicon.
Table 1. Gene targets, primer sequences, primer concentrations and amplicon sizes for the multiplex PCR
Primer Gene target
Virulence
factor ⁄ gene Sequence (5¢-)
Final concentration
(lM)
Amplicon size
(bp)
StFh Human estA STIh TTTCGCTCAGGATGCTAAACCAG 0.4 151
StRh CAGGATTACAACACAATTCACAGCAGTA 0.4
StFp Porcine estA STIp CTTTCCCCTCTTTTAGTCAGTCAACTG 0.4 160
StRp CAGGATTACAACAAAGTTCACAGCAG 0.4
PS3 vtx1 VT1 GTTTGCAGTTGATGTCAGAGGGA 0.25 260
PS4 CAACGAATGGCGATTTATCTGC 0.25
PS5 eae Intimin GGYCAGCGTTTTTTCCTTCCTG 0.15 377
PS6 TCGTCACCARAGGAATCGGAG 0.15
PS7 vtx2 VT2 GCCTGTCGCCAGTTATCTGACA 0.5 420
PS8 GGAATGCAAATCAGTCGTCACTC 0.5
PS9 eltA LTI AAACCGGCTTTGTCAGATATGATGA 0.45 479
PS10 TGTGCTCAGATTCTGGGTCTCCT 0.45
PS11 ipaH IpaH TTGACCGCCTTTCCGATACC 0.1 647
PS12 ATCCGCATCACCGCTCAGAC 0.1
PS13 16S rDNA 16S rDNA GGAGGCAGCAGTGGGGAATA 0.25 1062
PS14 TGACGGGCGGTGTGTACAAG 0.25
R = A or G; Y = C or T.
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Assay specificity with clinical isolates in
comparison with DNA hybridisation
The multiplex PCR method was compared with a
DNA hybridisation technique for 500 stool sam-
ples originating from patients with diarrhoea
(Table 3). Stool samples were first cultured on
SSI enteric medium plates, from which colonies
and areas of confluent growth were selected and
tested by DNA hybridisation and multiplex PCR.
When the analysis was based on colonies, there
was agreement between the two methods for 495
samples (466 negative and 29 positive). An addi-
tional five samples were positive only by PCR.
Depending on the amount of stool material and
the inoculation density, each plate might have
a significant amount of confluent growth,
Table 2. Results obtained using the multiplex PCR method for 142 reference strains from the International Escherichia and
Klebsiella Centre (WHO)
E. coli
group ⁄
Shigella No. of strains Serotype (no. of each serotype)
Virulence profile
estA vtx1 eae vtx2 eltA ipaH Negative
A ⁄EEC 23 Orough:H8 (1), Orough:H33 (1),
O4,O123:H– (1), O35,O135:H11 (1),
O51:H49 (1), O86:H8 (2), O103:H2 (1),
O111:H38 (1), O114:H49 (1), O116:H+ (1),
O118:H8 (1), O121:H19 (1), O125ab:H5 (1),
O126:H6 (1), O129: H11 (1), 132:H34 (1),
O145:H– (3), O145:H34 (1), O157:H7 (1),
O177:H25 (1)
+
EPEC 9 O26:H– (3), O55:H7 (1), O111:H– (1),
O111:H9 (1), O114:H– (1), O127:H– (1),
O142:H34 (1)
+
EIEC 13 O+:H– (2), O28ac:H– (2), O64:H– (2),
O121:H– (1), O124:H30 (1), O143:H– (2),
O144:H– (1), O172:H– (1), O173:H– (1)
+
Shigella 12 S. sonnei (3), S. flexneri 6 (2), S. flexneri 1b (2),
S. flexneri 2a (1), S. boydii 1-7 (1),
S. dysenteriae 2-7 (1), Shigella non-agglutinable (2)
+
Shigella 3 S. dysenteriae Type 1 + +
DAEC 4 O15:H– (1), O21:K–:H11 (1), O21:10 (1),
O36:H4 (1)
+
EAggEC 8 O24:H+ (1), O92:H+ (1), O92:H33 (1),
O103:H+ (1), O107:H+ (1), O113:H– (1),
O150:H28 (1), O153:H2 (1)
+
Non-pathogenic 3 O9:K+:H4 (1), OR:K?:H25 (1), OR:H48 (1) +
ETEC 8 Orough:H– (1), O6:H16 (1), O8:H9 (1),
O17:Hrough (1), O39:H12 (1),
O78:K–:H11 (1), O128ac:H+ (1), O148:H28 (1)
+ +
ETEC 5 O8:K+:H9 (1), O27:K?:H7 (1), O27:K–:H20 (1),
O115:K?:H5 (1), O148:H28 (1)
+
ETEC 7 Orough:H– (1), O8:K+:H9 (1), O8:H9 (1),
O25:K+:H– (1), O56:H– (1), O167:Hrough (1),
O169:H– (1)
+
VTEC 9 O26:H– (1), O26:H11 (1), O157:H– (5),
O157:H7 (2)
+ + +
VTEC 19 O26:H11 (5), O103:Hrough (1), O103:H2 (4),
O145:H+ (3), O145:H28 (2), O157:H– (1),
O157:K:H– (1), O157:H7 (1), O157:K–:H7 (1)
+ +
VTEC 19 O26:H– (1), O26:H11 (5), O103:H2 (3),
O145 (1), O145:H– (5), O157:H– (1),
O157:H7 (4)
+ +
Total 142
A ⁄EEC, attaching and effacing Escherichia coli; EPEC, enteropathogenic E. coli; EIEC, enteroinvasive E. coli; DAEC, diffuse adherence to cells E. coli; EAggEC,
enteroaggregative E. coli; ETEC, enterotoxigenic E. coli; VTEC, verocytotoxin-producing E. coli.
16S -
ipaH -
eltA -
estA -
vtx2 -
vtx1 -
eae -
- 1000 bp
- 500 bp
- 100 bp
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 1. PCR results obtained with 13 selected reference
strains. Lanes: 1 (all genes), ETEC (estA and eltA), VTEC
(vtx1, vtx2 and eae) and EIEC (ipaH); 2, VTEC (vtx1, vtx2
and eae); 3, EIEC (ipaH) and ETEC (estA and eltA); 4, EIEC
(ipaH); 5, ETEC (estA and eltA); 6, ETEC (eltA); 7, ETEC
(estA); 8, EPEC (eae); 9, VTEC (vtx1 and eae); 10, VTEC (vtx2
and eae); 11, VTEC (vtx1 and vtx2); 12, VTEC (vtx1); 13,
VTEC (vtx2); and 14, 100-bp DNA ladder.
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containing cell material originating from thou-
sands of different colonies. In order to test the
sensitivity of the multiplex PCR in practice, a
sweep of the confluent growth on each plate was
therefore tested by PCR and DNA hybridisation.
PCR analysis of the sweeps was positive for all
samples that were also positive using the single
colony procedure. In addition, 11 previously
negative samples were positive following PCR
analysis of the sweeps. None of these samples
was positive following DNA hybridisation with
the extracted sweep material. Single colonies were
isolated from five of the 11 PCR-positive samples.
Sensitivity with pure cultures
The sensitivity of the multiplex PCR was tested by
analysing ten-fold serial dilutions of DEC refer-
ence strains mixed with non-pathogenic E. coli
(Fig. 2). The detection limit for the ipaH, eltA and
estA genes was 100 CFU ⁄PCR in the presence of
106 non-target cells (Fig. 2, lanes 1–10), while the
vtx1, vtx2 and eae genes were detectable at
1000 CFU ⁄PCR in the presence of 106 non-target
cells (Fig. 2, lanes 12–21). When the analysis was
performed in the absence of the non-target cells, a
ten-fold higher sensitivity was found for all genes
(data not shown).
Analysis of spiked stool samples
Stools were spiked with ten-fold serial dilutions
of a VTEC strain, or with an ETEC and an EIEC
strain. For each strain combination, two bloody
and two non-bloody stool samples were extracted
using either the KingFisher mL system or the
QIAamp DNA Stool Kit, followed by analysis
with the multiplex PCR. Each virulence gene was
detected at a concentration of 106 CFU ⁄mL of
extracted stool using both extraction procedures,
except one bloody stool extracted using the
KingFisher mL system, from which no DNA
amplicons were obtained. The spiked stools were
also cultured on SSI enteric medium, followed by
PCR with selected colonies, which resulted in a
detection limit of 105 CFU ⁄mL of stool.
DISCUSSION
This study describes the development of a mul-
tiplex PCR method for the detection of the most
important DEC groups, namely ETEC, EPEC,
VTEC and EIEC. Each pathogen is identified by
the presence and combination of six virulence
genes: eltA, estA, vtx1, vtx2, eae and ipaH. Primers
directed towards all six virulence genes, as well as
a 16S rDNA gene serving as a positive PCR
control, were included in the multiplex assay. The
method was 100% specific when tested with a
representative reference strain collection that
included 127 different E. coli strains and 15
Shigella spp. Also, no cross-reactions were
observed with 13 non-E. coli gastrointestinal path-
ogens. Therefore, the method appears to be well-
suited for detection of DEC in culture material.
However, genetic assays do not allow a distinc-
tion between EPEC and attaching and effacing
E. coli, as the virulence factor(s) responsible for
Table 3. Comparison of results obtained using multiplex
PCR and DNA hybridisation for the identification of
colonies grown from 500 clinical stool samples on SSI
enteric medium plates
Gene(s)
ID by both methods
with colonies
ID only by PCR
with colonies
ID only by PCR
with confluent growtha
Negative 466
eltA 3
eae 20 2 7 (3)
vtx1 1 1 1 (0)
vtx1 + eae 1
vtx2 1 1
ipaH 3 1 3 (2)
Total positive 29 5 11 (5)
aNo. of samples from which single positive colonies were subsequently obtained is
shown in parentheses.
16S -
ipaH -
eltA -
estA -
- vtx1
- eae
- vtx2
-16S
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Fig. 2. Sensitivity of the multiplex PCR with pure cultures.
DEC reference strains were serially diluted ten-fold and
mixed with a non-pathogenic Escherichia coli strain, result-
ing in each dilution containing 106 non-pathogenic E. coli,
and 107)10)1 and 0 DEC in lanes 1–10 and 12–21. Lanes:
1–10, reference strain ETEC (estA and eltA) and EIEC
(ipaH); 11, 100-bp DNA ladder; 12–21, reference strain
VTEC (vtx1, vtx2 and eae). When strains containing estA,
eltA and ipaH were diluted, positive signals were obtained
until a concentration of 100 CFU ⁄PCR (lane 6) was
reached. When a strain containing vtx1, vtx2 and eae was
diluted, positive signals were obtained until a concentra-
tion of 1000 CFU ⁄PCR (lane 16) was reached.
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this differentiation have not been identified to
date; currently, this can only be done by serotyp-
ing [39]. Also, ipaH- and vtx1-positive strains
must be further identified by biochemical tests, as
these genes may also be present in Shigella spp.
[4]. Finally, because of the diffuse virulence
profile of EAggEC, these strains were not inclu-
ded in the development of this PCR method.
As both human estA and porcine estA have
been found in humans [4], both of these variants
were included in the PCR. Separate primer pairs
were designed for each variant because of
sequence diversity, but the products (151 and
160 bp) were indistinguishable when analysed by
the present agarose gel electrophoresis. Primers
were not designed to detect the gene encoding
STII ⁄ STb (estB) (accession nos M35729 and
AY028790), as these variants are rarely found in
humans [4,40]. The primers for estA did not align
with Y. enterocolitica heat-stable enterotoxin
(D63578), V. cholerae non-O1 heat-stable entero-
toxin (accession no. M97591) or EAggEC heat-
stable enterotoxin 1, EAST1 (accession no.
AB042005), although they share some sequence
similarities. Primers towards the heat-labile en-
terotoxin were designed to match human and
porcine eltA only, as eltB has not been associated
with human disease [4]. The eltA primers did not
match the related V. cholerae cholera enterotoxin
gene ctxA (accession no. AF452584). Because of
sequence conservation between EIEC and Shigella
spp., primers for the ipaH gene were designed to
match all variants from both species, and primers
for vtx1 matched all variants within subtypes vtx1
and vtx1c from VTEC and Shigella dysenteriae type
I. Primers targeted to vtx2were designed to match
all variants, except subtype vtx2f (accession no.
AJ270998), which was too divergent to be inclu-
ded and has little human relevance [41,42].
However, vtx2 genes with a high degree of
homology have been described previously in
Enterobacter cloacae (accession no. Z50754) [43]
and C. freundii (accession no. X67514) [44], and
these genes are also amplified by the present
method. Primers for the amplification of eae
contained one degenerate nucleotide each, and
were designed to match all subtype variants.
The sensitivity analysis showed that each
pathogen could be detected by the multiplex
PCR at a level of 101)102 CFU ⁄PCR when pure
cultures were analysed. This level of sensitivity is
in the same range as that found by others when
analysing pure cultures [20,26,32], and is an
acceptable sensitivity for a multiplex reaction
analysed subsequently by agarose gel electro-
phoresis and ethidium bromide staining. How-
ever, when 106 non-target cells were present, the
sensitivity of detection for each locus dropped
ten-fold. This finding has also been reported
previously [45], and may be caused by the
reduced possibility of physical contact among
the PCR reagents. Information concerning sensi-
tivity in the presence of non-target cells is espe-
cially important in the context of analysing mixed
cultures, such as stool samples. In such instances,
the virulence loci of interest may be highly
diluted in relation to non-target DNA. The pre-
sent sensitivity analysis with pure cultures
showed that each pathogen could be detected at
a level of 102)103 CFU ⁄PCR in the presence of 106
non-target cells. Thus, positive samples can be
identified correctly if the positive bacterial cell
material accounts for 1 ⁄ 1000 of the total cell
material.
The PCR method was compared with a colony
dot-blot DNA hybridisation technique for the
analysis of stool cultures, as the latter method was
the preferred routine diagnostic method at the
Statens Serum Institut between 1997 and 2003.
Both methods gave concordant results for 495 of
500 samples, while five samples were positive
only by PCR. Ideally, these five samples should
have been tested by other methods to exclude
false-positive results. When confluent growth on
the plates was subjected to PCR and DNA
hybridisation, 11 previously negative samples
were positive only by PCR. However, only five
of these 11 samples could be re-isolated as single
positive colonies when the confluent growth was
streaked out on a new plate, probably because
relatively few positive cells are hidden in the
confluent growth. No studies were performed to
determine the detection limit of DNA hybridisa-
tion, but these observations probably reflect a
greater sensitivity of the PCR analysis compared
with DNA hybridisation.
To reduce repetitive manual work and poss-
ible cross-contamination, the present method
was performed using eight-channel pipettes
and microtitre plates in all steps, including
sample collection and preparation, PCR and
gel loading. As generally recommended for
routine diagnostic PCR, the various steps were
performed in separate rooms with unidirectional
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sample flow [46,47]. To reduce possible contam-
ination, UNG-dUTP was used, and all pre-PCR
and PCR work areas were illuminated by UV
light at night. The 16S rDNA positive control
primers were designed to detect all Gram-
negative bacteria, and hence PCR analyses of
negative samples can be validated, even if they
contain no E. coli.
The multiplex PCR method was used in
conjunction with DNA purified from spiked
stools using two different commercial kits. Both
methods are based on DNA liberation in lysis
buffer, and subsequent DNA purification fol-
lowing binding to immobilised silica. With the
exception of one bloody stool extracted by the
KingFisher mL system, all spiked stools were
detected correctly by both methods at a level of
‡106 CFU ⁄mL of stool. Compared to the detec-
tion limit for pure cultures plus non-target cells,
both commercial extraction methods performed
well with respect to recovery of DNA and
removal of PCR inhibitors known to be present
in blood and faecal material [48–52]. The relat-
ive reduced sensitivity for stool samples could
be the result of DNA loss during the extraction
procedure, and ⁄ or >106 CFU of non-target cells
in the original stools. The single bloody stool
sample that could not be amplified by PCR
might have exceeded the PCR-inhibitor-extract-
ing capacity of the KingFisher mL method. This
unsuccessful amplification was recognised by
the absence of the 16S rDNA control band,
which highlights the need for a second PCR or
another type of analysis.
Previous studies have reported up to 100-fold
higher sensitivities when DNA was extracted
from spiked stool samples [53–56], possibly
caused by differences in extraction methods
and ⁄ or the larger number of gene targets includ-
ed in the present multiplex PCR. When the
spiked stools were investigated following growth
on SSI enteric medium plates, with morpholog-
ically different colonies being selected for the
multiplex PCR analysis, a sensitivity limit of
105 CFU ⁄mL stool was obtained. Previous stud-
ies have reported sensitivities as low as
100 CFU ⁄ g of stool following the use of pre-
PCR enrichment steps [28,29], but this has the
disadvantage of a more lengthy procedure before
the isolation of single positive colonies. Whether
or not clinical samples are cultured before PCR,
the approach described in the present study
appears to be valuable for routine diagnostic
identification of DEC.
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